Published • loading... • Updated
This ETF Is Up Nearly 17% in a Month and Doesn't Own a Single Share of Nvidia
The biotech fund’s equal-weighted portfolio of small- and mid-cap drug developers helped drive the gain, while its zero NVIDIA stake insulated it from chip volatility.
Summary by 247wallst.com
1 Articles
1 Articles
This ETF Is Up Nearly 17% in a Month and Doesn't Own a Single Share of Nvidia
Biotech is having a moment, and the numbers are hard to ignore. The SPDR S&P Biotech ETF (NYSEARCA:XBI) climbed 17.27% over the trailing month ending July 1, 2026, a run that would look right at home in the AI trade. The twist: XBI owns exactly zero shares of NVIDIA (NASDAQ:NVDA), the chipmaker that has defined ... This ETF Is Up Nearly 17% in a Month and Doesn’t Own a Single Share of Nvidia
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
